Wim Weber on independent clinical research in Europe

Earlier this month the workshop on the “Future of Independent Academic Clinical research in Europe” took place in the Académie royale de médecine de Belgique, housed in a palace neighbouring King Albert’s  in Brussels. Greeting you at the entrance is a statue of the Belgian mathematician Adolphe Quetelet (he of the index), but entering is hampered by scaffolding, […]

Read More…

Richard Lehman’s journal review – 20 September 2010

JAMA  15 Sep 2010  Vol 304 1173  Medical students dominate this week’s JAMA. These are American medical students, who all have degrees in something else before they start medicine, so they should be well rounded, relaxed human beings in the prime of youth, enjoying a new and interesting course of study which will result in their […]

Read More…

Rahim Rezaie: A neglected resource for neglected diseases

What does a recently developed meningitis vaccine, the the anti-malarial drug ASMQ, and balaglitazone have in common? The meningitis vaccine is a partnership involving the Program for Appropriate Technology in Health (PATH), the WHO and the Serum Institute of India (Pune).  ASMQ was developed by Drugs for Neglected Diseases initiative (DNDi), a public-private-partnership (PPP) including […]

Read More…

Domhnall Macauley on a postgraduate study day at Trinity College, Dublin

Bright eyed students wandered though the ancient cobbled courtyards of Trinity in the September sunshine- bursting with anticipation of the new term. “On Raglan Road on an Autumn Day….” The poet Patrick Kavanagh’s words came to mind- an echo of timeless repetition.  In contrast, we headed off to  the PhD and MD students of the […]

Read More…